AGENUS INC Investment Income, Net
AGENUS INC (AGEN) reported Investment Income, Net of $18.79 thousand for the 12-month period ending 2011-12-31, per its 10-K filed 2012-03-06.
Discontinued › Income Statement › Other Income
us-gaap:InvestmentIncomeNet · last filed 2012-03-06
- AGENUS INC investment income, net for the quarter ending 2011-06-30 was $4.47K, a 58.01% decline year-over-year.
- AGENUS INC investment income, net for the quarter ending 2010-06-30 was $10.63K.
- AGENUS INC investment income, net for fiscal 2011 was $18.79K, a 49.98% decline from fiscal 2010.
- AGENUS INC investment income, net for fiscal 2010 was $37.56K, a 72.68% decline from fiscal 2009.
- AGENUS INC investment income, net for fiscal 2009 was $137.48K.
| Period end | Investment Income, Net 3 month | Investment Income, Net 6 month | Investment Income, Net 12 month |
|---|---|---|---|
| 2011-12-31 | $18.79K 10-K · filed 2012-03-06 | ||
| 2011-06-30 | $4.47K 10-Q · filed 2011-08-05 | $11.79K 10-Q · filed 2011-08-05 | |
| 2010-12-31 | $37.56K 10-K · filed 2012-03-06 | ||
| 2010-06-30 | $10.63K 10-Q · filed 2011-08-05 | $18.73K 10-Q · filed 2011-08-05 | |
| 2009-12-31 | $137.48K 10-K · filed 2012-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |